DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,472,093 | +22.6% | 22,056 | +18.6% | 0.22% | +15.0% |
| Q2 2023 | $4,464,000 | +4.6% | 18,600 | +9.8% | 0.19% | -9.2% |
| Q1 2023 | $4,268,802 | +6.0% | 16,937 | +11.7% | 0.21% | -15.2% |
| Q4 2022 | $4,025,360 | +4.2% | 15,166 | +1.4% | 0.24% | -4.7% |
| Q3 2022 | $3,864,000 | +8.7% | 14,959 | +6.7% | 0.26% | +18.1% |
| Q2 2022 | $3,554,000 | -15.5% | 14,019 | -2.2% | 0.22% | -3.1% |
| Q1 2022 | $4,206,000 | +26.3% | 14,338 | +41.7% | 0.22% | +14.9% |
| Q4 2021 | $3,330,000 | +16.1% | 10,122 | +7.5% | 0.19% | +6.0% |
| Q3 2021 | $2,867,000 | +6.4% | 9,416 | -6.2% | 0.18% | +12.3% |
| Q2 2021 | $2,695,000 | +32.7% | 10,041 | +11.2% | 0.16% | +29.4% |
| Q1 2021 | $2,031,000 | +2.2% | 9,026 | +0.9% | 0.13% | +4.1% |
| Q4 2020 | $1,988,000 | +1.6% | 8,948 | -1.5% | 0.12% | -4.7% |
| Q3 2020 | $1,957,000 | +20.7% | 9,088 | -0.9% | 0.13% | +7.6% |
| Q2 2020 | $1,622,000 | +27.7% | 9,175 | 0.0% | 0.12% | +16.8% |
| Q1 2020 | $1,270,000 | -9.8% | 9,175 | 0.0% | 0.10% | +17.4% |
| Q4 2019 | $1,408,000 | +5.4% | 9,175 | -0.8% | 0.09% | +3.6% |
| Q3 2019 | $1,336,000 | +1.0% | 9,250 | -0.0% | 0.08% | +5.1% |
| Q2 2019 | $1,323,000 | +8.3% | 9,254 | 0.0% | 0.08% | +9.7% |
| Q1 2019 | $1,222,000 | +122.2% | 9,254 | +73.5% | 0.07% | +105.7% |
| Q4 2018 | $550,000 | -27.6% | 5,334 | -80.4% | 0.04% | -16.7% |
| Q3 2018 | $760,000 | +46.2% | 27,194 | +416.4% | 0.04% | +40.0% |
| Q2 2018 | $520,000 | -99.9% | 5,266 | -14.0% | 0.03% | -6.2% |
| Q1 2018 | $599,308,000 | +21.5% | 6,121 | +15.2% | 0.03% | +28.0% |
| Q4 2017 | $493,152,000 | +8.2% | 5,313 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $455,749,000 | +1.7% | 5,313 | +0.0% | 0.02% | 0.0% |
| Q2 2017 | $448,279,000 | +11.2% | 5,312 | +12.7% | 0.02% | +4.2% |
| Q1 2017 | $403,018,000 | +9.9% | 4,712 | 0.0% | 0.02% | +4.3% |
| Q4 2016 | $366,782,000 | -14.3% | 4,712 | -13.7% | 0.02% | -17.9% |
| Q3 2016 | $428,166,000 | +5.8% | 5,462 | +36.3% | 0.03% | 0.0% |
| Q2 2016 | $404,707,000 | -40.3% | 4,007 | -43.9% | 0.03% | -40.4% |
| Q1 2016 | $677,490,000 | +94.8% | 7,142 | +76.0% | 0.05% | +88.0% |
| Q4 2015 | $347,725,000 | -17.3% | 4,057 | -17.8% | 0.02% | -13.8% |
| Q3 2015 | $420,682,000 | +19.0% | 4,937 | +19.5% | 0.03% | +45.0% |
| Q2 2015 | $353,658,000 | +2.7% | 4,132 | +1.8% | 0.02% | 0.0% |
| Q1 2015 | $344,439,000 | -0.9% | 4,057 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $347,725,000 | +18.7% | 4,057 | +5.2% | 0.02% | +11.1% |
| Q3 2014 | $293,055,000 | -67.7% | 3,857 | -66.5% | 0.02% | -66.0% |
| Q2 2014 | $906,733,000 | +2.4% | 11,517 | -2.5% | 0.05% | -3.6% |
| Q1 2014 | $885,525,000 | -14.9% | 11,807 | -12.4% | 0.06% | -19.1% |
| Q4 2013 | $1,040,038,000 | +11.6% | 13,472 | +0.2% | 0.07% | -1.4% |
| Q3 2013 | $932,146,000 | +2.5% | 13,447 | -6.4% | 0.07% | -5.5% |
| Q2 2013 | $909,115,000 | – | 14,362 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |